Cagrilintide starts amylin receptors in the brainstems area postrema (a key satiety center) to enhance fullness signals, further slows gastric emptying through different mechanisms than GLP-1, reduces postprandial glucagon secretion, and may enhance leptin response
In contrast, reproductive outcomessuch as hormonal profiles, ovulation, and pregnancyshow greater cross-study fluctuation
There are also some limitations in this study, such as the relatively small number of patients and lack of samples of patients with a more advanced stage of NSCLC, such as stage IV, since ser/gly metabolism hyperactivation is associated to poor prognostic advanced NSCLC
In the withdrawal trial, continuing preserved loss far better than switching to placebo, which regained about 14% over a year. The metabolic benefit fades in proportion to the weight regained, so a taper plus protein and resistance training beats a hard stop